home / stock / bivi / bivi articles

BIVI Articles, BioVie Inc. - From 06/20/24

Stock Information
Company Name: BioVie Inc.
Stock Symbol: BIVI
Market: OTC
Website: biovieinc.com
Menu
BIVI BIVI Quote BIVI Short BIVI News BIVI Articles BIVI Message Board
Get BIVI Alerts

News, Short Squeeze, Breakout and More Instantly...
BioVie to Present Protocol Design for Upcoming Phase 2 Trial of Bezisterim in Patients with Early Parkinson's Disease at 2024 ATMRD Congress | Benzinga

CARSON CITY, Nev., June 20, 2024 (GLOBE NEWSWIRE) -- BioVie Inc., (NASDAQ:BIVI) ("BioVie" or the "Company") a clinical-stage company developing ...
Join BioVie's Exclusive Live Investor Webinar and Q&A Session on June 26 | Benzinga

CARSON CITY, Nev., June 12, 2024 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI), ("BioVie" or the "Company"), a clinical-stage company developing...

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie | Benzinga

NEW YORK, March 19, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims...

BIVI 4-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages BioVie (BIVI) Investors with Substantial Losses to Contact Firm Before Mar. 19th Deadline in Securities Class Action | Benzinga

SAN FRANCISCO, March 18, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges BioVie Inc. (NASDAQ:BIVI) investors who suffered substantial losses to sub...
BIOVIE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against BioVie Inc. and Encourages Investors to Contact the Firm | Benzinga

NEW YORK, March 16, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds inves...

BIVI DEADLINE ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages BioVie Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 19 Deadline in Securities Class Action – BIVI | Benzinga

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVie...

TUESDAY DEADLINE: Berger Montague Advises BioVie Inc. (NASDAQ: BIVI) Investors to Inquire About a Securities Fraud Class Action by March 19, 2024 | Benzinga

PHILADELPHIA, March 14, 2024 (GLOBE NEWSWIRE) -- Berger Montague advises investors that a securities fraud class action lawsuit has been filed a...
Class Action Filed Against BioVie Inc. (BIVI) - March 19, 2024 Deadline to Join – Contact Levi & Korsinsky | Benzinga

NEW YORK, March 13, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioVie Inc. ("BioVie" or the "Company&#...

BIVI DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action – BIVI | Benzinga

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioVi...

BioVie Announces Pipeline Update and Near-Term Clinical Priorities | Benzinga

Recently completed financing provides sufficient funds for near-term Parkinson's Disease priority Plans for Phase 2b trial of NE3107 as first...
Previous 10 Next 10